Management and Treatment of Primary Membranous Nephropathy With a Positive PLA2R Marker
Author Information
Author(s): Muacevic Alexander, Adler John R, Metuku Rajesh, Wynn Austin B, Santos Raul
Primary Institution: Alabama College of Osteopathic Medicine
Hypothesis
What role do PLA2R antibodies play in the progression of primary membranous nephropathy in patients with HIV?
Conclusion
The presence of anti-PLA2R antibodies in a patient with HIV complicated the treatment and led to a decline in renal function, ultimately resulting in end-stage renal disease.
Supporting Evidence
- The patient had nephrotic range proteinuria and a history of HIV.
- Biopsy results confirmed membranous nephropathy with PLA2R positivity.
- The patient was treated with tacrolimus and cyclophosphamide.
Takeaway
This study looks at a patient with kidney problems caused by a specific antibody and HIV, showing how these factors can make treatment harder and lead to serious kidney failure.
Methodology
The study involved a case presentation of a patient with nephrotic syndrome, biopsy results, and treatment outcomes.
Potential Biases
Potential bias in treatment decisions based on the unique combination of HIV and PLA2R positivity.
Limitations
The study is based on a single case, which may not be generalizable to all patients with primary membranous nephropathy.
Participant Demographics
A 35-year-old female with a history of hyperlipidemia and HIV.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website